Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations. by Santini, V, Prebet, T, Fenaux, P, Gattermann, N, Nilsson, L, Pfeilstöcker, M, Vyas, P, List, A

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. by Wang, L, Fidler, C, Nadig, N, Giagounidis, A, Della Porta, MG, Malcovati, L, Killick, S, Gattermann, N, Aul, C, Boultwood, J, Wainscoat, J

Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias by Cappellini, M.D., Porter, J., El-Beshlawy, A., Li, C.K., Seymour, J.F., Elalfy, M., Gattermann, N., Giraudier, S., Lee, J.W., Chan, L.L., Lin, K.H., Rose, C., Taher, A., Thein, S.L., Viprakasit, V., Habr, D., Domokos, G., Roubert, B., Kattamis, A., Investigators, EPIC Study